An error occurred on this page.
These results could be incomplete or invalid. Staff have been notified.



Project measures / variables set:   CSNA03   dist_l60_cont_in

ID, description, units MPD:90382   dist_l60_cont_in   distance traveled, last 60 min (post-injection), on successive days, saline control, founders   [cm]  
Measures • day:    • 1    • 2    • 3    • 5    • 7    • 9    • 11    • 12    • 19
Data set, strains CSNA03   inbred w/CC8   9 strains     sex: both     age: 8-14wks
Procedure open field test
Comparisontimecourse, same cohort
Ontology mappings

  SIDE-BY-SIDE STRAIN CURVES
Values
Graph Type
Dimensions Width:  ×  Height: px
Plot Options


  OVERLAPPING STRAIN CURVES
Data
Dimensions px
Toggle Series   
Plot Options

CSNA03 - distance traveled, last 60 min (post-injection), on successive days, saline control, founders





  ANOVA, Q-Q NORMALITY ASSESSMENT

ANOVA Summary          "within" = Within error     "between" = Between Error (Animal ID)

Factor DF Sum of squares Mean sum of squares F value p-value (Pr>F)
within   day 8 607740456.3921 75967557.049 3.3414 0.0009
within   day:sex 8 149120040.549 18640005.0686 0.8199 0.5851
within   day:strain 64 2628065788.6295 41063527.9473 1.8061 0.0002
within   day:sex:strain 64 1369447892.8618 21397623.326 0.9412 0.6082
within   Residuals 784 17824591411.111 22735448.2285
between   sex 1 4722175577.2566 4722175577.2566 10.9485 0.0013
between   strain 8 54670051022.2684 6833756377.7835 15.8443 < 0.0001
between   sex:strain 8 5774284155.7737 721785519.4717 1.6735 0.1144
between   Residuals 98 42268095203.6165 431307093.9145

Q-Q normality assessment based on residuals

  


  INDIVIDUAL MEASURES
ProjectIDTreatmentMeasure / Variable Description PanelStrains
tested
SexAge
CSNA03 90382 open field test (none) distance traveled, last 60 min (post-injection), on successive days, saline control, founders   [cm]   day 1  dist_l60_cont_in_d1 inbred w/CC8 9 both 8-14wks
CSNA03 90388 open field test (none) distance traveled, last 60 min (post-injection), on successive days, saline control, founders   [cm]   day 2  dist_l60_cont_in_d2 inbred w/CC8 9 both 8-14wks
CSNA03 90394 open field test (none) distance traveled, last 60 min (post-injection), on successive days, saline control, founders   [cm]   day 3  dist_l60_cont_in_d3 inbred w/CC8 9 both 8-14wks
CSNA03 90400 open field test (none) distance traveled, last 60 min (post-injection), on successive days, saline control, founders   [cm]   day 5  dist_l60_cont_in_d5 inbred w/CC8 9 both 8-14wks
CSNA03 90406 open field test (none) distance traveled, last 60 min (post-injection), on successive days, saline control, founders   [cm]   day 7  dist_l60_cont_in_d7 inbred w/CC8 9 both 8-14wks
CSNA03 90412 open field test (none) distance traveled, last 60 min (post-injection), on successive days, saline control, founders   [cm]   day 9  dist_l60_cont_in_d9 inbred w/CC8 9 both 8-14wks
CSNA03 90418 open field test (none) distance traveled, last 60 min (post-injection), on successive days, saline control, founders   [cm]   day 11  dist_l60_cont_in_d11 inbred w/CC8 9 both 8-14wks
CSNA03 90424 open field test (none) distance traveled, last 60 min (post-injection), on successive days, saline control, founders   [cm]   day 12  dist_l60_cont_in_d12 inbred w/CC8 9 both 8-14wks
CSNA03 90430 open field test (none) distance traveled, last 60 min (post-injection), on successive days, saline control, founders   [cm]   day 19  dist_l60_cont_in_d19 inbred w/CC8 9 both 8-14wks